DRGEM Corporation (KOSDAQ:263690)
5,340.00
+10.00 (0.19%)
At close: Mar 27, 2026
DRGEM Market Cap
DRGEM has a market cap or net worth of 58.18 billion as of March 27, 2026. Its market cap has decreased by -4.18% in one year.
Market Cap
58.18B
Enterprise Value
52.81B
Revenue
102.75B
Ranking
n/a
PE Ratio
8.59
Stock Price
5,340.00
Market Cap Chart
Since November 22, 2018, DRGEM's market cap has decreased from 76.56B to 58.18B, a decrease of -24.01%. That is a compound annual growth rate of -3.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 58.18B | - |
| Dec 30, 2025 | 58.18B | -6.54% |
| Dec 30, 2024 | 62.26B | -45.72% |
| Dec 28, 2023 | 114.68B | -1.79% |
| Dec 29, 2022 | 116.78B | -13.05% |
| Dec 30, 2021 | 134.30B | -29.41% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 22, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neofect | 100.17B |
| Remed | 96.28B |
| Noul Co.,Ltd. | 84.12B |
| QuantaMatrix | 80.84B |
| Hironic | 74.74B |
| JPI Healthcare | 63.56B |
| Genoray | 54.48B |
| Genesystem | 44.54B |